Integer Holdings

ITGR on NYSE. Integer Holdings makes medical devices for other medical device companies. Market value $4.3bn.

Watch this stockFree. We tell you when something changes.

Price checks use the past 12 months to September 2026. Quality checks use five annual reports, the latest for the year to December 2025.

Should I look at this?

Good business, but not cheap right now

See cheaper Health care stocks on the list

This is not advice. Check the numbers below.

Compare with another stock

Cash yield
past 12 months to September 2026
1.9%low

For every $100 of what the whole company costs, it produced $1.90 of spare cash in the past 12 months. A savings account pays about $4.

Price to profit
past 12 months to September 2026
37.0×full

You pay 37.0 years of operating profit for the business. The average large US company costs around 18.

Return on capital
five annual reports to December 2025
5.2%five-year median

Each dollar kept in the business earns 5 cents a year. Above 10 is good.

Quality score: 81 of 100. Price score: 23 of 100. Our list needs 70 on quality and 60 on price.

$126.97 a share, 86% above its 1-year low

Over the past year the price has ranged from $68.18 to $133.06.

Pays no dividend

Price from Monday’s close (16 November).

Five years of cash, in billions

0.1
0.0
0.1
0.1
0.1
0.1
2021202220232024202512 monthsto Sep '26
Revenue
$1.2bn$1.3bn$1.6bn$1.7bn$1.9bn
Operating margin
11.1%8.5%10.5%12.1%11.9%
Debt to equity
0.620.660.640.630.70
Shares outstanding
0.03bn0.03bn0.03bn0.04bn0.03bn

Health checks

  • Free cash flow positive5 of 5 years
  • Accounting looks honest (Beneish)Nothing unusual
  • Financial strength (Piotroski)6 of 9
  • Profit backed by cash (accruals)Yes
  • Debt0.70× equity
  • Revenue growth, five yearsStrong, 11.5% a year
  • Buying back its own sharesRoughly flat

The quarter to September 2026

How the business did, compared with the same quarter a year earlier.

  • Sales: $450 million last quarter, down 4% on a year ago.
  • Profit: $15 million, down 62% on a year ago.
  • It keeps 8 cents of each $1 of sales as operating profit, down from 12 cents a year earlier.
  • Spare cash over the past 12 months: $82 million, down from $121 million.
  • 3% fewer shares than a year ago. Each share owns a bit more of the company.
  • Debt is $1.3 billion more than cash, up from $1.2 billion a year ago.
Sales by quarter
Sales by quarter
Quarter toAmount
December 2024Not reported
March 2025$437m
June 2025$476m
September 2025$468m
December 2025$472m
March 2026$440m
June 2026$464m
September 2026$450m
Profit by quarter
Profit by quarter
Quarter toAmount
December 2024$33m
March 2025-$22m
June 2025$37m
September 2025$40m
December 2025$49m
March 2026$17m
June 2026$24m
September 2026$15m

From the company's quarterly reports to the SEC.

Dates

Next results (estimated)
n/a
Last annual report (10-K)
23 February 2026
Next quarterly (estimated, 10-Q)
28 January 2027

Who owns it

6 long-term investors we follow own it, down from 7 last quarter. 329 funds in all.

Jun '25
Dec '25
Jun '26

Sold out this quarter

Largest holders overall

From 13F filings for the quarter ended 30 June 2026.

Big holders and activists

5 investors own more than 5%.

  • BlackRock, Inc.
    Passive investor
    14.7%
    Since 30 June 2025
  • NOMURA HOLDINGS INC
    Passive investor
    at least 6.5%+1.1 pts
    (filed with 1 related holder)
    Since 30 September 2026
  • 6.0%
    Since 31 March 2026
  • Glazer Capital, LLC
    Passive investor
    at least 5.5%
    (filed with 1 related holder)
    Since 13 November 2026
  • 5.3%
    Since 31 March 2026
  • Sold down below 5%
    Since 31 March 2025
  • Invesco Ltd.
    Passive investor
    Sold down below 5%
    Since 30 September 2026
  • Tarheel Investors III L.P.
    Strategic holder
    Sold down below 5%
    Since 17 November 2026
    What they said

    Item 4 of the Schedule 13D is hereby amended and supplemented as follows: On November 17, 2026 (the "Closing Date"), pursuant to the previously disclosed Merger Agreement, among other things, (a) Merger Sub merged with and into the Issuer, with the Issuer surviving the Merger as…

    Read the filing
  • The Vanguard Group
    Passive investor
    Sold down below 5%
    Since 13 March 2026

From Schedule 13D and 13G filings: anyone owning more than 5% must file one.

What insiders did

No insider bought shares on the open market in the last 12 months. 3 sold $5m.

  • Thor Kirk K
    Chief Human Resources Officer
    Sold
    Date
    15 September 2026
    Shares
    11,767
    Price
    $126.23
    Value
    $1m
  • Thor Kirk K
    Chief Human Resources Officer
    Sold
    Date
    14 September 2026
    Shares
    19,773
    Price
    $126.25
    Value
    $2m
  • Senn Andrew
    President, Growth & Innovation
    Sold
    Date
    8 September 2026
    Shares
    9,408
    Price
    $126.30
    Value
    $1m
  • Thomas Tommy P
    VP, Corporate Controller
    Sold
    Date
    13 March 2026
    Shares
    825
    Price
    $85.00
    Value
    $70,125

From Form 4 filings: insiders must report trades in their own company's shares within two days.

Warning signs in its filings

Problems the company itself reported to the SEC, in its own words.

None of the warning signs we check for were found.

We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.

We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 23 Feb 2026, plus the 10-Q filed 29 Oct 2026 and 13 later 8-Ks.

A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.

What could go wrong

  • It isn't cheap on profits: 37.0× operating profit.

Whether the price already reflects the risks is what the deep dive is for.

The deep dive

Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.

  • What the business is worth, as a range, and the margin of safety at today’s price
  • Prices to start buying, buy, and buy hard
  • The three things that would make this a mistake
  • Every number footnoted to the filing it came from

A big holder just moved. The deep dive shows what the business is worth.

Create a free account to run it

Your first deep dive is free.

What a finished deep dive looks like

Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.